Podcasts about Phase

Letzte Woche war es still hier im Podcast – rund um das Osterwochenende. Doch in meinem Business war es alles andere als ruhig.Ein Reel auf meinem englischen Instagram-Kanal ist viral gegangen – mit über 2,5 Millionen Views, 16.000 Speicherungen und einem Wachstum von 2.500 auf über 13.000 Follower innerhalb weniger Tage.Was wie ein Übernachterfolg aussieht, ist in Wahrheit das Ergebnis von Monaten voller Hingabe, Klarheit und Energiearbeit.In dieser Folge nehme ich dich mit hinter die Kulissen: warum dieses Video nicht „einfach Glück“ war wie ich mit Energie gearbeitet habe, statt mit Content-Output was ein Space Healing mit dem viralen Durchbruch zu tun hat und warum sich Durchbruch oft genau dann zeigt, wenn wir am wenigsten damit rechnenDiese Folge ist für dich, wenn du gerade in der „stillen Phase“ steckst, wenn du dich fragst, ob sich dein Dranbleiben lohnt – und wenn du bereit bist, dein Wachstum nicht nur mit Strategie, sondern mit Energie zu führen.DanijelaP. S.: Ab Juli gibt es wieder einen freien Platz im 1:1 Business Mentoring für dich und dein Unternehmen?Die Zusammenarbeit in diesem Rahmen ist nicht für viele. Aber für genau die Richtigen.Es ist für Unternehmer und Unternehmerinnen, die spüren, dass sie bereit sind, größer zu gehen – ohne sich zu verlieren.Die Klarheit suchen – nicht in noch mehr To-do-Listen, sondern in ihrer Essenz.Die geführt werden wollen – auf energetischer Ebene, strategisch, menschlich.In meinem 1:1 Mentoring arbeiten wir eng, direkt und tief.Volle Nähe. Individuelle Ausrichtung.Energie. Struktur. Raum.Wenn du fühlst, dass dieser Weg deiner ist, dann schreib mir.Wir sprechen in Ruhe, was für dich möglich ist.Denn du bist nicht hier, um zu funktionieren.Du bist hier, um zu führen.Nicht irgendwann. Jetzt.Links zur Folge: Folge mir auf Instagram: @unfolding_space Direktanfrage zum Mentoring: https://unfolding-space.de/private-mentoring/ Mehr über meine Arbeit: https://unfolding-space.de/

Episode SummaryThe highly informed and deeply compassionate Amy Emerson joins Jef Szi and the How Humans Work Podcast for a remarkable conversation about the evolving landscape of psychedelics. With her extensive involvement and leadership in the Multidisciplinary Association of Psychedelic Studies (MAPS)* and their multi-year effort to get MDMA approved by FDA as a therapeutic medicine for PTSD. There are few better than Amy who can speak to the state of psychedelics for medical use in society. Not only does Amy share her honest appraisal about FDA drug approval process and members of congress on the Hill, she gives us the little known and fascinating history of MDMA. Some highlights are Sasha and Ann Shulgin's groundbreaking contributions, the reputational damage MDMA suffered in the 90's, the long-game efforts of Rick Doblin and others, the powerful way MDMA works on the brain, and the remarkable promise MDMA has shown to help people suffering with PTSD. Put together as a whole, Emerson offers us a destigmatized and inspiring view of MDMA beyond the common street descriptions of Ecstasy and Molly. From MDMA and the Medical Model, Amy then helps us see the many other use-cases for psychedelics that have a long and varied history. Building on issues of trauma and the importance of spiritually reconnecting with ourselves, we walk through the psychological benefits that can come with right-use of psychedelics.Finally, this conversation opens the visions of what future of psychedelic use in society through thoughtful contexts that track safety concerns and how, much like meditation, these ‘medicines' can have a place in our society like Buddhist and meditation practices have entered our culture. All in all, Breaking the Stigma is a podcast of significance, as it invites us to reconsider our biases around psychedelics at a time when our society is challenged by mental health matters like trauma and the pervasive disconnection from nature and spiritual renewal. ***** About: Amy Emerson is a highly respected leader in the field of psychedelic-assisted therapy. She was Lykos Therapeutics (formerly MAPS PBC) CEO for an important period in advancing MDMA-assisted psychotherapy for post-traumatic stress disorder (PTSD) as a drug with the FDAShe earned a Bachelor of Science in Genetics and Cell Biology from Washington State University and spent the early career involved in roles at pharmaceutical companies, where she contributed to the development of therapies in immunology, oncology, and vaccines .​In 2003, she began volunteering with the Multidisciplinary Association for Psychedelic Studies (MAPS), assisting with clinical research monitoring. Her expertise was instrumental in establishing MAPS' clinical department and managing the MDMA Clinical Development Program. When MAPS founded its Public Benefit Corporation (MAPS PBC) in 2014 to develop and commercialize MDMA-assisted therapy, Emerson was appointed CEO .​Under her leadership, the organization, later rebranded as Lykos Therapeutics, completed multiple Phase 2 and Phase 3 clinical trials and raised approximately $150 million in funding. The company grew to over 120 employees, all working toward the goal of obtaining FDA approval for MDMA-assisted therapy for PTSD .​Amy resigned form her CEO role in September 2024. Currently she is a senior advisor to Lykos and an independent psychedelic research consultant, awaiting the next big adventure.*****Chapters00:00 Introduction and Setting the Stage02:40 The Evolution of Psychedelic Research06:10 Understanding Stigma and Its Origins10:54 MDMA: From Therapy to Recreation16:33 Therapeutic Applications of MDMA20:28 Navigating the FDA and Drug Development24:45 Challenges

Im Vorfeld möglicher Friedensverhandlungen zwischen Russland und der Ukraine hat US-Präsident Donald Trump Russlands Präsidenten Putin öffentlich zur Zurückhaltung aufgerufen. Hintergrund sind massive russische Luftangriffe auf Kiew. Medienberichte sprechen von einem geheimen US-Friedensplan – und einem möglichen Rückzug der USA aus dem Verhandlungsprozess.

Ready to get results and be coached by us? Apply to join our next plan now www.fitfemaleproject.com or follow us on Instagram @fitfemaleprojectVictoria – Upper body workouts feel short in Phase 5—finishing in 40–45 mins. Is that okay?Annabel – Are pork chops or beef meatballs good protein sources, or should I stick to lean meats?Sarah – What are the most effective exercises for building ab strength?Nicola – Is it okay to go over protein if I'm still under my calorie target?Shin – Going on an active holiday—how do I stay on track without feeling guilty for skipping workouts?Emily – Why is my single-leg press much lower than my two-leg press? Am I overthinking it?Aimee – Is it normal to hit a weight loss plateau and then start seeing results again?Laura S – Weight stalled this week—could indulgence over Easter be the reason?Mary – Fell off track during a busy week and Easter—how do I bounce back without undoing progress?Gemma – Struggling with fatigue and nausea—can I track yoga instead of weight workouts?

You've probably heard about hydrogen water, electrolyte water, or structured water… But none of them come close to what Rob Gourley discovered. We're talking about a fifth phase of water that doesn't just hydrate you—it energizes your cells, grounds your body, boosts oxygen at the cellular level, and helps flush out toxins with zero stress on your kidneys. Rob Gourley is the mechanical engineer behind Watt-Ahh®, an oxygen- and hydrogen-infused water charged with electrons and powered by a gas he created called di-tetra gas. It has got a massive electron load and delivers pure bioenergetic support to your mitochondria. In this episode, Rob explains how this supercharged water works on a cellular level to raise voltage, drive detox, and replenish the body's actual energy currency—not sugar or fat, but oxygen loaded with electrons.   He also shares the story behind creating the WIT machine, a breakthrough device now being used to reverse eye damage, neurological disorders, and circulation issues without pharmaceuticals or surgery. You'll never look at water the same way again.   "Watt-Ahh® is probably the simplest, most efficient way to help your body deal with toxins in the environment. It's like a little red wagon—it carries nutrients in and carries the garbage out." ~ Rob Gourley   In This Episode: - What is Watt-Ahh®? - How it delivers hydrogen and oxygen - Dentist's story: reversing extreme mercury toxicity - Vision restoration with WIT gas infusion and eye healing - Nerve damage repair and diabetic limb salvage with Watt-Ahh®   - Applications of Watt-Ahh water - How Watt-Ahh® aids dementia and Parkinson's patients - Cellular Health: how Watt-Ahh enhances cell function - Lymphatic drainage improvement for better detoxification - Increasing nutrient absorption with Watt-Ahh - Recommendations for daily Watt-Ahh® consumption For more information, visit https://www.myersdetox.com    Heavy Metals Quiz: Find out your toxicity score and receive a free video series on detoxification. Visit https://heavymetalsquiz.com    Resources Mentioned: Bon Charge: Get 15% off red light therapy face masks and other EMF protection products with code WENDY at https://boncharge.com  Puori PW1 Protein Powder: The cleanest protein powder available, third-party tested against 200+ contaminants. Get 20% off with code WENDY at https://puori.com/wendy  Tru Energy Skincare: Frequency-enhanced facial serum with over 2,000 frequencies for collagen, elastin, and skin nutrition. Get a special deal at https://trytruenergy.com/wendy  Watt-Ahh® Water: Learn more about Rob Gourley's revolutionary water at https://aquanew.com  or call 888-936-AQUA (2782)   About Rob Gourley: Rob Gourley is a mechanical engineer and founder of AquaNew, the company behind Watt-Ahh®. He's also the creator of the WIT machine, a revolutionary device used to infuse di-tetra gas into water to activate its 5th-phase properties. With over 30 years researching the energetic potential of water, including a career that began during the Alaskan pipeline project, Rob has helped thousands of people restore their health by rethinking what water really is and what it can do for the human body. Learn more at https://aquanew.com    Disclaimer The Myers Detox Podcast was created and hosted by Dr. Wendy Myers. This podcast is for information purposes only. Statements and views expressed on this podcast are not medical advice. This podcast, including Wendy Myers and the producers, disclaims responsibility for any possible adverse effects from using the information contained herein. The opinions of guests are their own, and this podcast does not endorse or accept responsibility for statements made by guests. This podcast does not make any representations or warranties about guests' qualifications or credibility. Individuals on this podcast may have a direct or indirect financial interest in products or services referred to herein. If you think you have a medical problem, consult a licensed physician.

In this engaging conversation, Kyle Hartman, a doctor of physical therapy and owner of Monterey Pelvic Health, discusses the importance of sexual wellness and intimacy in relationships. The hosts explore various aspects of intimacy, communication, and the societal expectations surrounding sex. They emphasize the need for open dialogue about desires and boundaries, especially in the context of parenthood. The conversation also touches on the significance of redefining what sex means and how to maintain connection and intimacy in busy lives. Kyle shares personal anecdotes and practical advice, making the discussion relatable and insightful for listeners.Moment- Kyles Rec for top tear UNDIES~⁠https://hu-ha.com/?srsltid=AfmBOooiL4rt_Ri695bll40Yz654thuDtwOSDTpRGl8R0rfd8xGMaGfl⁠

“This isn’t just an incremental shift, it’s a drastically different treatment dynamic,” says Rob Barrow, CEO of MindMed. On this episode of Vanguards of Health Care, Barrow speaks with Bloomberg Intelligence analyst Jean Rivera Irizarry about how MM120, a pharmaceutically optimized form of LSD, could transform the treatment landscape for anxiety and depression. They explore MindMed’s unique no-therapy approach to psychedelic trials, the design of its pivotal Phase 3 studies, and how it’s navigating regulatory hurdles to bring this once-taboo drug class into the mainstream.See omnystudio.com/listener for privacy information.

…Perspektive. Deine Wahrnehmung ist schlechter als du denkst.Worauf du dich in dieser Phase verlassen kannst? Die Antwort gibt es in dieser Folge! Freut mich, dass du eingeschaltet hast!Fühl dich gedrückt, BeaInstagram: beatrix.hersich Du möchtest auf die Bühne?https://www.strongpassion.at/kontakt/Sichere dir Stage Insights hier:https://www.strongpassion.at/bodybuilding-stage-insights/

Video Version Only on HCPLive! In this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, discuss the top-line results from the ACHIEVE-1 trial evaluating orforglipron—an investigational, once-daily oral glucagon-like peptide-1 receptor agonist (GLP-1 RA) developed by Eli Lilly—for adults with type 2 diabetes (T2D) inadequately controlled by diet and exercise. Isaacs and Bellini emphasized the clinical significance of orforglipron's Phase 3 data in the ACHIEVE-1 trial, which demonstrated substantial reductions in A1c (1.3–1.6%) from a baseline of 8.0% and notable weight loss averaging 16 pounds (7.9%) at the highest dose over 40 weeks. Impressively, more than 65% of participants achieved an A1c below 6.5%, meeting the American Diabetes Association (ADA)'s target for diabetes control. The hosts highlighted the convenience advantage of orforglipron compared to oral semaglutide, which has strict dosing requirements. Oral orforglipron can be taken without food or water restrictions, potentially increasing adherence and reducing treatment burden. They also noted the drug's favorable safety profile, with gastrointestinal side effects similar in type and incidence to existing GLP-1 RAs, and no hepatic safety signals observed in the trial. Beyond glycemic control, Isaacs and Bellini discussed the broader implications for obesity treatment, pointing to the drug's potential utility in weight management, pending regulatory submission. They explored the possibility of using injectable GLP-1 RAs for initial weight loss followed by oral maintenance with orforglipron—potentially lowering costs and improving access. The conversation touched on the upcoming ACHIEVE trial series, which will explore orforglipron in head-to-head comparisons with other agents, its use in insulin-treated T2D, and future indications including cardiovascular risk and kidney disease. While optimistic, the hosts stressed the need for cardiovascular outcomes data to confirm orforglipron's safety and potential benefits in this domain. If confirmed, they suggested orforglipron could become a cornerstone oral therapy for T2D and obesity. Relevant disclosures for Isaacs include Eli Lilly and Company, Novo Nordisk, Sanofi, Abbott Diabetes Care, Dexcom, Medtronic, and others. Relevant disclosures for Bellini include Abbott Diabetes Care, MannKind, Provention Bio, and others. Key Episode Timestamps 00:00:01 Discussion on OR for GLP-1 Receptor Agonist 00:02:13 Potential Impact and Patient Preferences 00:03:59 Safety and Market Potential 00:05:13 Cost and Transition Options 00:06:32 Future Trials and Side Effects 00:08:55 Cardiovascular Outcome Data and Conclusion

In this Health, Wellth & Wisdom Podcast episode, host and head coach, Nicole Hagen talks about what to do when you're done with dieting… but you still want to lose weight. Throughout the episode you'll hear about the three phases people go through when they stop dieting but still want to lose weight.Phase 1: You feel lost AF without rules Phase 2: You fear gaining the weight back Phase 3: You discover a better way - with support and so much more in-between. If you're at a place in your life where you know dieting doesn't work (because you've been there/done that - maybe more than a few times) but you still want to lose weight, this is a conversation you don't want to miss!Where to find me: IG: @nutritionwithnicoleCheck out my website HERE!Apply for 1:1 Nutrition Coaching HERE!

Join and become a member of this channel, high frequency tribe homesteadhttps://www.youtube.com/channel/UCUMRaiiNMl3m7LxtCPI2tJg/joinJoin, become a member of the tinfoil brickapocalypse channel https://www.youtube.com/channel/UCLUuANxKvah7VDw0VbuRlyA/joinPURCHASE merchandise and ARThttps://www.etsy.com/shop/malibuillusionFinancially support this channelhttps://www.paypal.me/malibuillusionTikTok accounthttps://www.tiktok.com/@malibuillusion?_t=8rVj6gq6x9q&_r=1Podcast https://open.spotify.com/show/37O8Yj1y37Gr4VvExbmnaaInstagram https://www.instagram.com/sneaky_insects/profilecard/?igsh=MzRlODBiNWFlZA==Contact me via emailhamishpatterson69@yahoo.comBitcoin send to this address35uDZx9QNZiCbcrtxRMxo97E2Xvpecv9T7Etherium0xBB5190B3735F23329d7E7594C35c2AB9067eB7F2Bit chute channel https://www.bitchute.com/profile/CWxMDL2DOlCZNEW CHANNELSLEGO owl & illusion channelhttps://www.youtube.com/c/LEGOwithOwlIllusionLEGO Instagram https://www.instagram.com/brickshipearth/ Head in a Baghttps://www.youtube.com/channel/Contact me via emailhamishpatterson69@yahoo.com

Episode 230Can't play corridos in MexicoCoachella and CancunEconomy is wonky - Phase 55When should you go to a funeralEaster BrawlWWE bought a Mexican Wrestling PromotionTexas TornadoTemu and Shein increasing pricesTrump's crap and his parade

April 23, 2025 ~ Jeff Monosso Fox News Correspondent and WJR Contributor discusses Health Secretary RFK Jr's plan to phase out 8 common food dyes.

Del Bigtree is a former producer of the award winning medical show The Doctors. He's the producer of "Vaxxed" a documentary about a CDC whistle-blower. And Del is a returning guest to The Optimal Performance Podcast.  In this episode we cover: • Del Challenges scientists to show a single stat that shows that this is more deadly than the flu • A thorough analysis of the limited data we have  • The vaccine development process and what is original antigenic sin - vaccines only attack part of a protein, but allows other viruses - which then causes people to have the virus, without symptoms. • Pharma insiders, are now working/leading the regulatory agencies we're paying to help keep us safe. • They're already admitting that they are going to rush it to market, without sufficient safety tests, no placebo groups, 45 people. Will be the most scrutinized safety test in history. Phase 1 trials are going to be very tricky to manage • We may never go back to where we were a month ago. 

The Filtered Fragments (OG Filtrate)Joel TopfJennie LinSwapnil HiremathSpecial Guest Brad Rovin GN God and second author from The Ohio StateKoyal Jain GN Specialist from UNCAlfred Kim Rheumatologist from Washington UniversityEditing bySimon Topf and Nayan AroraThe Kidney Connection written and performed by by Tim YauShow NotesJoel's monologue One of the most surprising facts of nephrology is that despite conventional wisdom that lupus nephritis is an antibody mediated disease, that over a decade ago, the LUNAR investigtors were unable to find a significant benefit when rituximab was added to conventional therapy. And this was after the equally negative phase 2 trial of rituximab, EXPLORER.In fact, despite this finding rituximab has been able to burough its way into treatment of many nephrologists and rheumatologists as well as the KDIGO guidelines where it is suggested for patients with persistent disease activity or inadequate response to initial standard-of-care therapy.This long conflict is now coming to an end. Obinutuzumab, a newer, better monoclonal antibody targeting the same CD20 that we grew to love with rituximab, but it has a number of advantages.One. It is humanized antibody rather than a chimeric mouse-human antibodyTwo. It's cytotoxicity is not complement dependent an particular advantage if you want to deploy it ina disease where hypocomplementemia is a disease characteristicThree, and most importantly, it causes stronger and deeper b-cell depletion than rituximab. Better B-cell depletion in the blood and tissue.And this brings us to tonight's topic, we had already seen the phase two results of obinutuzumab which, unlike EXPLORER, were positive, we will look at the phase three regency trial. This makes the third novel lupus nephritis drug in the last 4 years. We continue to remake glomerular nephritis.LUNAR: Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study PubmedEXPLORER: Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial PubmedREGENCY: Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis NEJM | NephJCNOBILITY: B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial Annals of Rheumatic DiseaseComparison of intravenous and subcutaneous exposure supporting dose selection of subcutaneous belimumab systemic lupus erythematosus Phase 3 program PubMed CentralClass 5 lupus nephritis is slow to respond Long-term Use of Voclosporin in Patients with Class V Lupus Nephritis: Results from the AURORA 2 Continuation Study ACR Meeting abstractTubular SecretionsSwap: Young Adult novel I Must Betray You by Ruta Sepetys (Amazon)Koyal: Taekwondo (Wikipedia)Jennie: these unprecedented times Trump NYT: Administration Freezes $1 Billion for Cornell and $790 Million for Northwestern, Officials SayAl: Acquired PodcastBrad: The Feather Thief by Kirk Wallace Johnson (Amazon)Joel: Paradise on Hulu (Wikipedia)

ICYMI: Hour Two of ‘Later, with Mo'Kelly' Presents – Thoughts about a new study that examines the practice of disciplining your children by way of “spanking” across the globe…PLUS – A look at the rollout of Popeyes new pickle flavor explosion AND your weekly horoscopes with the dog breed that best represents you based on your zodiac sign - on KFI AM 640…Live everywhere on the iHeartRadio app

How will we scale humanoid robot product to hundreds of thousands and millions of units? In this TechFirst we do a deep dive with Apptronik CEO Jeff Cardenas. We chat about Apptronik's Apollo, his recent $400M+ funding round, the partnership with manufacturing giant Jabil, and much more.We also talk about innovations in AI that have accelerated robot learning and dexterous manipulation, the challenge of scaling manufacturing, and Apptronik's future vision.

AP correspondent Haya Panjwani reports on the phasing out of artificial dyes in the US food supply.

Research shows that spirituality can benefit mental health and improve overall well-being. And it can play a meaningful role in helping people cope with life's challenges, like living with MS. This week, Dr. Mana Ali Carter, a rehabilitation psychologist at MedStar National Rehabilitation Hospital in Washington D.C., joins me to discuss the positive effects that spirituality can have on the mind and body, and how it's been shown to make a difference for people living with MS.   We're also sharing encouraging initial reports from a Phase 1 clinical trial for KYV-101, Kyverna's investigational CAR-T therapy for MS. We'll tell you about a positive report on two years of data from a Phase 2 clinical trial extension study for Frexalimab, a novel investigational disease-modifying therapy from Sanofi. We'll explain how the decision to discontinue federal matching funds for designated state health programs will have a direct impact on some people living with MS. And we'll tell you how you can register for the National MS Society's webinar in support of restoring federal funding for the MS Research Program. We have a lot to talk about! Are you ready for RealTalk MS??! This Week: How spirituality can make a difference if you're living with MS  :22 Initial reports from a Phase 1 clinical trial for a CAR-T therapy are encouraging  1:15 Two years of data from a Phase 2 extension study of Frexalimab are positive  3:07 The federal government will no longer provide matching funds for designated state health programs  5:47 The National MS Society is hosting a virtual event to support restoring federal funding for the MS Research Program  8:38 Dr. Mana Ali Carter explains how spirituality can make a difference in your life if you're living with MS  11:27 Share this episode  30:40 Have you downloaded the free RealTalk MS app?  31:01 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/399 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com Become an MS Activist Web: https://nationalmssociety.org/advocacy Email: msactivist@nmss.org Participate in a Sanofi Clinical Trial https://sanofistudies.com Register for a Virtual Event: Restore the MS Research Program https://nmss.quorum.us/event/23043 Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 399 Guests: Dr. Mana Ali Carter Privacy Policy

The Pinball Show Episode 174: Trough Jam 2025 Phase 2: Dune, King Kong, & More Potter Teases   Hosts: Dennis Kriesel & Zach Meny   - Dune Pinball Revealed By Barrels Of Fun Pinball - King Kong: Myth Of Terror Island Released By Stern Pinball - First Impressions, Sales, Production, & Analysis Of Phase 2 Games - Dennis & Zach Disagree On King Kong Pinball & Elwin Pinography  - Stern Pinball Production Updates - EXCLUSIVE MEMBERSHIP CONTENT: Behind The Scenes Of Phase 2 Game Releases - Pinball Market Trends™   EXCLUSIVE CONTENT AND TPS MEMBERSHIP CAN BE FOUND AT Patreon.com/thepinballshow   Remember to purchase your next pinball or arcade machine from Flip N Out Pinball flipnoutpinball.com zach@flipnoutpinball.com greg@flipnoutpinball.com   Follow, like, and subscribe to The Pinball Show (TPS), the industry's most popular podcast!   email: thepinballshow@gmail.com website: thepinball.network youtube: youtube.com/thepinballshow instagram: @thepinballshowpodcast tik tok: @thepinballshow review: thisweekinpinball.com/the-pinball-show/ store: flipnoutpinball.com membership: patreon.com/thepinballshow  

What does it truly take to help clients achieve lasting health? This episode of Real Training. Better Living dives deep into the "Reclaim, Ascend, & Self-Mastery" framework, offering a fresh perspective on personalized fitness strategies.   Join Tommy and Chris as they discuss how understanding client motivations can shape effective training approaches, share real-life examples of overcoming challenges, and explore actionable insights that fitness professionals can apply right away. Whether you're a coach, a fitness enthusiast, or someone on your own health journey, this episode provides the tools and inspiration to take control of your well-being. Discover how to tailor strategies that meet individual needs and how the client-centric approach can pave the way for long-term success. Looking to see where you're at in your own fitness or coaching process? Tune in and start your transformation today! Contents in this Video: [00:00:00] - Welcome & Mapping the Client Journey [00:03:12] - Digging Deeper: Understanding Client Motivations [00:06:38] - Real Talk: Tools, Mistakes & Client Trust [00:10:15] - Phase 1: Reclaiming Health After Setbacks [00:14:00] - Phase 2: Ascend — Building Strength & Confidence [00:18:05] - Phase 3: Self-Mastery & Training Autonomy [00:23:15] - Testing Limits: Setting Goals & Embracing Challenges [00:27:45] - Final Takeaways: Sustainable Fitness & Self-Awareness Learn More About District H Strength & Fitness: Website: https://districthsf.com/ Instagram: https://www.instagram.com/district_h_strength/ FaceBook: https://www.facebook.com/DistrictHStrength YouTube: https://www.youtube.com/@districthstrengthandfitness

Der FCK streicht mit einem 0:2 in Braunschweig die dritte Niederlage der Spätsaison in Folge ein und verliert wichtige Punkte im Kampf um den Relegationsplatz in Liga 2. Woran liegt der Ergebniseinbruch? Ausgleichende Gerechtigkeit oder vercoachte Spielsituationen? Oder eine Mischung aus allem? Hört unsere Meinung zur aktuellen Situation des FCK, der Rolle des Trainers in dieser Phase und der Frage, wohin es die letzten vier Spiele noch laufen könnte?

The FAME 3 trial 5-year results, TAVR at 5 years, pacers after TAVR, and mavacamten not a wonder drug are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I FAME 3 at Five Years Stents as Good as Surgery for Triple-Vessel Disease https://www.medscape.com/viewarticle/noninvasive-stents-good-surgery-triple-vessel-disease-2025a10007l4 Main trial NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2112299 Circulation 3-years https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.123.065770 5-year results Lancet 10.1016/S0140-6736(25)00505-7 https://linkinghub.elsevier.com/retrieve/pii/S0140673625005057 II TAVR in Low-Risk Patients at 5 years 5-Year TAVR, Surgery Outcomes Similar in Low-Risk Patients https://www.medscape.com/viewarticle/5-year-tavr-surgery-outcomes-similar-low-risk-patients-2025a10007zl EVOLUT Low-Risk 5 years https://www.jacc.org/doi/10.1016/j.jacc.2025.03.004 EVOLUT Editorial – We're Halfway There https://www.jacc.org/doi/10.1016/j.jacc.2025.03.428 PARTNER 3 Low-Risk https://www.nejm.org/doi/full/10.1056/NEJMoa2307447 NOTION at 5 years https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.118.036606 III The Matter of Pacemakers After TAVI JACC IV Study Badertscher https://www.jacc.org/doi/10.1016/j.jcin.2025.03.028 Assessing the quality of reporting of harms in randomized controlled trials published in high impact cardiovascular journals   IV Mavacamten Looks to Have Specific Indications EXPLORER HCM 10.1016/S0140-6736(20)31792-X External Link VALOR HCM https://jamanetwork.com/journals/jamacardiology/fullarticle/2809050 BMS Press Release https://news.bms.com/news/details/2025/Bristol-Myers-Squibb-Provides-Update-on-Phase-3-ODYSSEY-HCM-Trial/ FINAL THOUGHTS PRAGUE 25 https://bmjopen.bmj.com/content/12/6/e056522 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

Die Autorin Kristine Bilkau schreibt über die großen Fragen, die das ganz normale Leben an uns stellt, so klug, tief und unaufgeregt wie keine andere. In ihrem aktuellen Roman "Halbinsel" geht es um eine Mutter in der Lebensmitte und ihre Tochter, die eigentlich schon ausgezogen und berufstätig war, und nach einem Zusammenruch ins Elternhaus zurückkehrt.Leise, präzise und exemplarisch erzählt sie, wie es uns gelingen kann, in der Lebensmitte neu aufzubrechen. Und sie gibt so gute Denkanstöße, wir wir einander aus den Rollen entlassen, wenn die Kinder erwachsen werden. Aber nicht nur das: Der Roman stellt auch die Frage, was es mit unserem Verhältnis zueinander macht, dass wir, die Elterngeneration der jüngeren Generation die Welt in diesem Zustand hinterlassen. Unbedingt lesen, aber erstmal hören.Ein so tolles Gespräch mit Kristine Bilkau, die für diesen Roman übrigens den Preis der Leipziger Buchmesse erhielt. Sowas von zu Recht.Kristine Bilkau"Halbinsel", erschienen bei Luchterhand, 224 SeitenInstagram: @kristinebilkauHier geht es zum Newsletter "Saisonwechsel" von der BRIGITTE.Hier geht es zum neuen meno_brigitte-Insta-Account.Hier geht es zu Dianas Instagram.Hier geht es zu Julias Instagram.WEITERE ANGEBOTE aus der BRIGITTE Redaktion:Krafttraining 50 plus: Forever Fit On Demand Kurs von BRIGITTE ACADEMYMasterclass Finanzen Basic: https://academy.brigitte.de/course/masterclass-finanzen-basic?utm_source=menoanmich&utm_medium=podcast&utm_campaign=mcf-basicKostenloses Webinar Rentenlücke berechnen: https://academy.brigitte.de/webinar-aufzeichnung-rentenluecke-berechnenETF Kurs: https://academy.brigitte.de/course/etf-kurs?utm_source=menoanmich&utm_medium=podcast&utm_campaign=etf-kurs-mOn Demand Video-Kurs "Wechseljahre: Wissen, was hiilft": https://academy.brigitte.de/course/wechseljahre?utm_source=podcast&utm_medium=meno&utm_campaign=wechseljahreDossier "Wechseljahre": https://produkte.brigitte.de/products/brigitte-dossier-wechseljahre?utm_campaign=briwebsite&utm_medium=link&utm_source=podcastmenoanmichDossier "Stoffwechsel anregen": https://produkte.brigitte.de/products/stoffwechsel-anregen?utm_source=podcast&utm_medium=menoanmich&utm_campaign=stoffwechselDossier "Gehen oder blieben?": https://produkte.brigitte.de/products/gehen-oder-bleiben?utm_source=podcast&utm_medium=menoanmich&utm_campaign=gobEs gibt auch einen MENO AN MICH-Rabattcode, MENO15 (gilt für viele BRIGITTE-Angebote).Ihr habt Anregungen, wollt uns Eure Geschichte erzählen oder selbst bei uns zu Gast im Podcast sein? Dann schreibt uns beiden persönlich, worüber Ihr gern mehr wissen würdet, was Euch bewegt, rührt, entsetzt und Freude macht an podcast@brigitte.de. Wir freuen uns auf Euch! Und bewertet und abonniert unseren Podcast gerne auch auf Spotify, iTunes, Amazon Music oder Audio Now. Noch mehr spannende Beiträge findet Ihr zudem auf Brigitte.de sowie dem Instagram- oder Facebook-Account von BRIGITTE –schaut vorbei! Mehr Infos zu unseren Werbepartnern findet ihr hier: https://linktr.ee/menoanmich.podcast+++Unsere allgemeinen Datenschutzrichtlinien finden Sie unter https://datenschutz.ad-alliance.de/podcast.html +++Wir verarbeiten im Zusammenhang mit dem Angebot unserer Podcasts Daten. Wenn Sie der automatischen Übermittlung der Daten widersprechen wollen, klicken Sie hier: https://datenschutz.ad-alliance.de/podcast.htmlUnsere allgemeinen Datenschutzrichtlinien finden Sie unter https://art19.com/privacy. Die Datenschutzrichtlinien für Kalifornien sind unter https://art19.com/privacy#do-not-sell-my-info abrufbar.

In this episode of the Phase 4 Podcast, we sit down with Deion – a high-energy, fun-loving, and deeply compassionate peak performance strategist who's redefining what it means to thrive. A former NCAA basketball player turned startup founder, Deion's world shifted dramatically when he was diagnosed with multiple sclerosis. But instead of slowing down, he doubled down on his purpose.Armed with an MBA and a passion for positive psychology, Deion now helps people unlock their edge and achieve amazing results in life and business. Whether you're an entrepreneur, athlete, or just someone hungry to grow, his insights into mindset, strategy, and resilience will light a fire in you.We dive into the mental game behind true performance, what it really takes to bounce back stronger, and how embracing adversity can lead to your greatest breakthroughs. Get ready for a conversation packed with energy, wisdom, and real talk from someone who's walked the walk.****If you enjoyed this episode, please follow the show, share it with a friend and consider leaving a review on Spotify and/or YouTube  ⁠https://open.spotify.com/show/4JfM1ZitoXTP6DXXfUbqRm?si=9f68c2de30a5446f⁠  ****www.youtube.com/@Phase4PodcastConnect with Deion Wells-Ross https://www.linkedin.com/in/deion-wells-ross-mba-55a052120/ Connect with Jp ⁠⁠https://linktr.ee/NextStepsAcademy 

Draulio Araujo, professor at the Brain Institute in the University of Rio Grande Norte in Natal, Brazil, has been studying ayahuasca for more than 20 years. It's a psychedelic plant used in rituals in South America that has also been researched for its potential to treat depression. The effects of ayahuasca can last for hours and also lead to side effects including vomiting and diarrhea. The active psychedelic drug in ayahuasca is DMT, and so Dr. Araujo and his colleagues decided to conduct the first test of DMT itself, which is also an endogenous chemical and has been demonstrated to be safe. Hosted on Acast. See acast.com/privacy for more information.

Phase one of Appleton International Airport expansion project is complete. See omnystudio.com/listener for privacy information.

Nach dem Ende des Zweiten Weltkriegs im Mai 1945 lagen zahlreiche deutsche Städte in Trümmern, und Schätzungen zufolge war bis zu 50% der urbanen Bausubstanz zerstört. In dieser schwierigen Zeit traten die sogenannten "Trümmerfrauen" hervor – Frauen, die in entscheidender Weise am Wiederaufbau der Städte mitwirkten.  Da viele Männer als Soldaten im Einsatz waren oder gefallen waren, übernahmen die Frauen weitgehend die Verantwortung für die Wiederherstellung des zerstörten Landes. Die Trümmerfrauen symbolisierten somit nicht nur den Wiederbeginn, sondern auch die Widerstandskraft der Gesellschaft in einer Phase des tiefgreifenden Wandels. Ihr Engagement war nicht nur physisch äußerst herausfordernd, sondern besaß auch eine immense psychologische Bedeutung. Sie vermittelten Hoffnung, Normalität und Zuversicht in einer Welt, die von Zerstörung und Verzweiflung gezeichnet war.

B shares her take on dating during the "in-between phase." That space between raising teenagers and the empty nest of kids at college. PLUS: Thinking about what YOU bring to the table and how men can be even more emotional than women. See omnystudio.com/listener for privacy information.

B shares her take on dating during the "in-between phase." That space between raising teenagers and the empty nest of kids at college. PLUS: Thinking about what YOU bring to the table and how men can be even more emotional than women. See omnystudio.com/listener for privacy information.

Dr. Amy B. Killen is a regenerative and longevity physician, Chief Medical Officer of Humanaut Health, and founder of the Human Optimization Project. In this hormone-packed episode, she breaks down everything we should have learned about menopause, sex, and hormone therapy—but didn't.We talk about:The truth about hormone replacement therapy (HRT)Why estrogen isn't the enemy—and how it can reduce mortality by up to 40%The biggest mistakes women make when navigating menopauseThe link between sex, sleep, and longevityCompounded medications, topical testosterone, and maximizing absorptionWhy now is your Queen Phase—and how to step into it with power and knowledgeDr. Killen is on a mission to stop the confusion and get women real, science-backed answers so they can feel strong, sexy, and vibrant at every age. Excellent episode and fantastic information!Links:

Welcome to Episode 15 The Echo Chamber, the final episode in the current series! In this edition, James and Michele talk about The Mutant Phase by Nicholas Briggs, released in December 2000 - the Fifteenth story in Big Finish's Main Range. Listening instructions are very straightforward - Buy The Mutant Phase from Big Finish Productions for just a few pounds (if you don't own it already of course!) Listen to it! Join us in the Echo Chamber, listen to what we thought and join in the discussion! Enjoy the show!

Got Health Questions or Comments?

As most of you know, our Patreon audience has the INSIDE access to the KF Show. The year 2025 will be an important one for Patreon specifically and if you'd consider jumping up to the $5 level it would sure help. The $10 level will remain and we now have a brand new $20 level as well! All members who join at that level will receive a sticker swag pack in the mail, you'll be IMMEDIATELY entered in the monthly prize grab, and you'll receive a phone call from one (or all) of us to chat up whatever you want for 30 minutes! Thank you SO MUCH to those of you who have joined in for the extra content that is only for Patreon supporters. To get in on the action and support the show with a minor financial contribution just click the link below to sign up. Join up via Patreon at patreon.com/KFSHOW ======================================== Presented with Holley - Back for 2025!  Phase 3 of Kibbe and Friends is officially here, and Holley is back for more fun, foolishness, and flying orange Chargers! Once again we're proud to be associated with the historic name that has made cars fast for years and years, and their innovations continue forward (as always)! Make sure that you visit Holley.com to place your speed parts orders - and THANK THEM for continuing on as the Title Sponsor of the KF Show!  ======================================== Reeces Challenge: We did the Reeces Challenge in this one to determine once and for all which Reeces Easter peanut-butter-and-chocolate product is the best. We did. We had guests as well. Then we alsmost threw up. Conclusion: the regular Reece's Egg is the best of all time (even the regular peanut butter cup). Dukes Review: Bo and Luke intercept some stolen diamonds. The leader of the crime ring fakes her identity as a newspaper reporter and the then hilarity ensues…..as the diamonds are pursued by Boss Hogg and Rosco - and hidden - without their knowledge - with Boss and Rosco, and then the diamonds are turned over to the FBI…..but it's not the real FBI, it's the fake FBI. But then Bo and Luke get them back. Everybody got that? In the meantime we get one more childlike fun where Rosco asks Boss to play with a Bugs Bunny doll and Cletus is sent to fetch 7 Corndogs for lunch, 1 for Rosco and 6 for Boss, and line that defines the Dukes of Hazzard that made every kid my age believe that a real stud of a man didn't throw footballs or play golf - they drove cars fast. 10 Dogs. Show Rating: 10 Corndogs! Legit Show Info: Season 4 - Episode 3 Title: Diamonds In the Rough Story by William Raynor & Myles Wilder Directed By: James Best Airdate: 10/23/81 Original Episode Review: KF Episode 73 - August of 2018  ======================================== Welcome to the High Performance Expo! We are pleased to announce that the all new High Performance Expo has joined us to share their inaugural event, the exclusive business and enthusiast show of the North Carolina Motorsports Association (NCMA), will be held from June 3-5, 2025, at the Charlotte Convention Center, followed by area-wide enthusiast activities. The event will bring together all segments of the racing, aftermarket, restoration, and performance community for the first time in the heart of the auto racing industry. We'll be bringing you more details until the show starts! Visit https://thehpx.com for details.   ======================================== National Parts Depot Presents: Bernie on the News! https://www.npdlink.com. The post K&F Show #327: The Full Blown Reeces Teenage Assist Easter Challenge (no Puke Bucket); Easter Dukes Review S4E04 first appeared on The Muscle Car Place.

Okay, this is it. This is the last of the Super Guides. It's a wild one and it's a long one! Matt and Hunter conquer the most important phase of the game and wind through every Strategy Card in the game. The discussion is wide reaching and is a great focal point for new and old listeners. We hope you enjoy it, and we hope you are excited for what happens next on the show. Thanks for listening! Music provided by Ben Prunty. Find more at benpruntymusic.com or benprunty.bandcamp.com Additional Music and Sounds by Brian Kupillas. https://wanderinglake.bandcamp.com/ To learn more about our Discord, Patreon, Merch, and more, visit https://spacecatspeaceturtles.com/

Send us a textERP Phase 0 is more than just a clever way to cut down on the zeroes in your total cost of ownership—it's the strategic groundwork that can make or break your entire implementation. This critical phase is where businesses assess their needs, document current processes, and align their objectives with the capabilities of a chosen ERP system. Think of it as building a zero-solid foundation: whether it's a retailer identifying supply chain gaps or a manufacturer validating workflow compatibility, Phase 0 is where hidden inefficiencies surface and alignment begins. Skipping this step often leads to costly delays, scope creep, and mismatched expectations. But embracing it? That's how you set your ERP project up for real, scalable success.In this episode, Sam Gupta engages in a LinkedIn live session with Jakob Bent Smed, Founder, JBS Advisory in a live LinkedIn session and discusses ERP Phase 0 stories.Background Soundtrack: Away From You – Mauro SommFor more information on growth strategies for SMBs using ERP and digital transformation, visit our community at wbs. rocks or elevatiq.com. To ensure that you never miss an episode of the WBS podcast, subscribe on your favorite podcasting platform. 

This week, I'm talking to my friend Bria Gadd, host of the popular podcast "The Period Whisperer." Through her own perimenopause journey, Bria transitioned from being a fitness expert to becoming an expert in functional medicine and nutrition centered on the menstrual cycle, especially for women in those critical years prior to menopause. Bria and I are discussing how to listen to your body to feel better by reducing energy demands and increasing energy input throughout the various stages of our cycle. You can reach Bria through her podcast or via the following links:

In this episode of Let's Combinate, host Subhi Saadeh welcomes back Skip Creveling, a global expert in program management and Six Sigma methodologies.Skip shares his extensive experience helping Fortune 500 companies optimize design processes, reduce risks, and drive innovation—especially in highly regulated industries like medical devices, pharmaceuticals, and aerospace.The discussion explores Skip's career transition from Eastman Kodak to the medical device sector, the importance of structured program management, phase gate processes, and the balance between going fast and ensuring thorough planning.Skip also delves into the differences between simple and complex projects and the necessity of having tailored project management templates for various project scales.The episode concludes with insights into how to manage risks effectively through tools like project and portfolio FMEAs, and the importance of data-driven decision-making in project execution.Timestamps:00:00 – Introduction and Guest Welcome00:19 – Skip's Background and Experience01:10 – Transition to Medical Devices and Pharma03:35 – Program and Project Management Insights06:03 – Phases and Gates in Product Development08:59 – Challenges and Strategies in Project Management10:51 – Examples of Project Management in Action13:28 – Importance of Planning and Risk Management18:10 – Templates and Tools for Effective Project Management29:49 – Final Thoughts and Contact InformationAbout the Host:Subhi Saadeh is a Quality Professional and host of Let's Combinate. With a background in Quality, Manufacturing Operations, and R&D, he has worked in large Medical Device and Pharma organizations to support the development and launch of hardware devices, disposable devices, and combination products for vaccines, generics, and biologics.Subhi currently serves as the International Committee Chair for the Combination Products Coalition (CPC), is a member of ASTM Committee E55, and has served on AAMI's Combination Products Committee.For questions, inquiries, or suggestions, please visit letscombinate.com or connect on the show's LinkedIn page.

Some call it the reset, but why now? Well, people are noticing the illusion that was life around them. The reset is The Great Distraction while new systems are put in place for a new system that is not as noticeable.  ☕ Support Civilization Cycle Podcast Buy As a Double Espresso

Im Sudan herrscht nach zwei Jahren Krieg eine der schwersten humanitären Katastrophen der Welt. Vertreterinnen und Vertreter von rund 20 Staaten beraten deshalb in London über eine Lösung des Konflikts. Gleichzeitig tritt der Bürgerkrieg in eine neue, gefährliche Phase ein. Alle Themen: (00:0 0) Intro und Schlagzeilen (01:21) Der Krieg im Sudan geht in eine neue, gefährliche Phase (05:20) Nachrichtenübersicht (10:02) Chinas Präsident Xi auf grosser Mission in Südostasien (14:53) USA: «Was wir an den Unis sehen, findet im ganzen Land statt» (21:18) Wer profitiert eigentlich von Trumps Wirtschaftspolitik? (26:14) Wird die Akademisierung der Schweiz zum Verhängnis? (30:04) Wenn KI die Archivdokumente schwärzt (36:11) Keine frohen Ostern für walisische Schafbauern

Can hormonal fluctuations across a single menstrual cycle alter arterial wave reflections and wasted pressure effort? In this episode, Associate Editor Dr. Jonathan Kirk (Loyola University Chicago) interviews author Dr. Ninette Shenouda (University of Delaware) and expert Dr. Sarah Baker (Mayo Clinic) about the latest study by Shenouda et al. investigating sex differences and ventricular arterial interactions. The authors wanted to understand how strategic phases of the menstrual cycle might affect the relationship between the left ventricle (LV) and the arterial system, as this relationship is crucial for maintaining adequate cardiac output and blood pressure. Given the established beneficial effects of estradiol on the vasculature, the authors hypothesized that their cohort of naturally menstruating premenopausal women would have favorable reductions in total peripheral resistance and favorable changes in the arterial wave reflection profile during the high hormone cycle phases, compared to age matched men. What were the unexpected findings? Listen now to find out.   Ninette Shenouda, Joseph M. Stock, Nicholas V. Chouramanis, Zoe R. Lincoln, Megan M. Wenner, Julio A. Chirinos, and David G. Edwards Favorable alterations in ventricular-arterial interactions across the menstrual cycle in healthy premenopausal women Am J Physiol Heart Circ Physiol, published February 28, 2025. DOI: 10.1152/ajpheart.00363.2024

**GUEST HOST** It wasn't a phase, mom will go over the life and crimes of teens and young adultsIn Part 2 of our deep dive into the Shanda Sharer case, we're joined by a guest host to explore the heartbreaking final hours of Shanda's life. We walk through the investigation that stunned the nation, the trials of the four teenage girls responsible, and where they are today. This is a tragic story with lasting consequences—one that continues to spark conversations about justice, rehabilitation, and the depths of human cruelty.Listener discretion is advised.Follow us on all social media!Facebook - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/bucketmurd⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Twitter - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twitter.com/TheMurderBucket⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/murdbucket/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok -⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@murderbucketpod⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://murderbucketpod.wordpress.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Last week, at the American Academy of Neurology annual meeting, Dr. Amit Bar-Or received the John Dystel Prize for Multiple Sclerosis Research for his multiple achievements that have advanced our knowledge of neuroimmunology, precision medicine, and biomarkers in MS. We talked with Dr. Bar-Or about how some of the latest discoveries in MS research would impact patient care.   Tolebrutinib, an investigational disease-modifying therapy, is currently making its way through the FDA's regulatory process. Last week, the results of the Phase 3 clinical trials for Tolebrutinib were published, and we're sharing the details. We'll also tell you about MindGlide, an AI-powered tool for analyzing MRI scans that will significantly reduce MRI exam times. We're talking about the results of the Phase 3 clinical trial for high-dose Ocrevus. And we'll tell you about a cell therapy that doesn't use stem cells that successfully repaired myelin in the mouse model of MS -- twice!  We have a lot to talk about! Are you ready for RealTalk MS??! Congratulations to Dr. Stephen Hauser and Dr. Alberto Ascherio  :22 This Week: The impact of breakthrough MS research on MS care  2:17 Results of the phase 3 clinical trials for Tolebrutinib have been published  3:07 An AI-powered tool for analyzing MRI scans will significantly reduce MRI exam times for patients  4:21 Results of the phase 3 clinical trial for high-dose Ocrevus  8:13 A cell therapy that doesn't use stem cells has successfully repaired myelin in the mouse model of MS -- twice!  10:14 Dystel Prize winner Dr. Amit Bar-Or discusses how some of the latest discoveries in MS  research will impact MS care  12:39 Share this episode  22:36 Have you downloaded the free RealTalk MS app?  22:56 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/397 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com Become an MS Activist Web: https://nationalmssociety.org/advocacy Email: msactivist@nmss.org RealTalk MS Episode 310: The Face Laughs While The Brain Cries: The Education of a Doctor with Dr. Stephen Hauser https://realtalkms.com/310 RealTalk MS ECTRIMS Extra: Results from the Phase 3 Clinical Trial for Tolebrutinib and Relapsing-Remitting MS with Dr. Jiwon Oh https://realtalkms.com/ectrims244 VIDEO: RealTalk MS ECTRIMS Extra: Results from the Phase 3 Clinical Trial for Tolebrutinib and Relapsing-Remitting MS with Dr. Jiwon Oh https://youtu.be/zcBmAHRTotA VIDEO: RealTalk MS ECTRIMS Extra: Results from the Phase 3 Clinical Trial for Tolebrutinib and Nonrelapsing Secondary Progressive MS with Dr. Robert Fox https://youtu.be/tJQ93qdlXrU STUDY: Tolebrutinib Versus Teriflunomide in Relapsing Multiple Sclerosis https://nejm.org/doi/full/10.1056/NEJMoa2415985 STUDY: Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis https://nejm.org/doi/full/10.1056/NEJMoa2415988 Enabling New Insights from Old Scans By Repurposing Clinical MRI Archives for Multiple Sclerosis Research https://www.nature.com/articles/s41467-025-58274-8 Fibroblast Technology https://fibrobiologics.com/technology/#cnsms Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 398 Guests: Dr. Amit Bar-Or Privacy Policy

Join the Refrigeration Mentor Hub here Learn more about Refrigeration Mentor Customized Technical Training Programs at www.refrigerationmentor.com/courses This episode of CO2 Experts is the second of a 2-part lesson on advanced CO2 refrigeration troubleshooting with Chris Brown, Application Engineering Manager of Danfoss (You can listen to Part 1 here). In Part 2, we dive into the technical side of CO2 system start ups - tips and things to look for to really be proficient on getting that rack up and running or getting to a point where you can start adding gas. We also focus optimizing controller settings, tuning, and ensuring effective pressure management.  In this episode, we discuss: -Controller tuning and receiver pressure -Understanding PI selection and tuning results -Troubleshooting rack superheat -Hot gas and liquid injection dynamics -Oil management -Booster systems and discharge pressure issues -Understanding medium temp suction pressures -Low temp discharge safety settings -Medium temp compressor issues and solutions -Suction Floating -Handling emergency shutdowns -Phase loss monitor checks -Troubleshooting charge loss -Leveraging manufacturer support Helpful Links & Resources: Danfoss Supermarket Support Danfoss YouTube Channel Chris Brown on LinkedIn Controller Talk Podcast S3 E13: “Inside Supermarket Refrigeration with Refrigeration Mentor, Trevor Matthews”  

If want to grow your heart-centered online business in sync with your unique gifts and vedic astrology, enrollment is now open for Thrive Online 2025 at https://www.quietmindastrology.com/thriveIt's officially the end of the eclipse portal. On Saturday, April 12th, we have a powerful Full Moon in Chitra Nakshatra, in the sign of Virgo — marking the celebration, the culmination, and the completion of everything you've been moving through over the past six weeks. The following day, Sunday, April 13th, is massive: Venus goes direct after her long retrograde journey that began March 2nd, and the Sun moves into Aries, beginning a fresh new solar cycle.This is a big week. And then, blessedly, we get a reprieve — a chance to rest, integrate, and begin anew. In this episode, I unpack how to work with the closing of the eclipse portal and Venus retrograde, while stepping into the bold, action-oriented Aries energy that defines the second half of April.Chitra Nakshatra's ruler is Vishvakarma — the celestial architect of the universe — and this Full Moon is about recognizing what you have built. Your ideas. Your creations. Your healing. This is Mars energy in its constructive, creative form. This isn't the time for conflict or confrontation — especially not on the 12th — but it is the time to perform, to lead, to build, to take care of your body, your home, your self-expression.Venus moves direct this week so I break down the 3-phase journey of Venus retrograde taht began in January:Phase 1 (Jan 27–Mar 2) – Surrender: Heightened romance, longing, idealism, but with potential illusions.Phase 2 (Mar 2–Apr 13) – See Clearly: Truth-telling, pattern recognition, karmic reckonings.Phase 3 (Apr 13–May 31) – Step Forward: Integration, recalibration, moving toward soul-aligned love and purpose.I share personal reflections of how this has shown up in my own life and invite you to explore what has been stirred in yours. You might still feel unclear, foggy, emotional — that's okay. It doesn't all need to make sense. This is a deeply spiritual time. Allow what's been hidden to come to the light.Then, as the Sun enters Aries — exalted, empowered — we step into initiation energy. This is your inner CEO, your builder, your independent, courageous self. Want to start a business? Launch a new project? Change your routine? From now through October is a golden time for aligned action.You don't have to overthink it. Just start. Start simple. Let your alignment guide your action, and your actions lead to achievement.5 Key Quotes from the Episode“This Full Moon in Chitra is the culmination of your becoming — a celebration of your creative power.”“Venus retrograde isn't about regret. It's about reflection, realignment, and realizing what truly matters.”“You've gone through a six-week portal — you're not the same person who started this journey.”“Sun in Aries is your green light — start now, keep it simple, and take action from alignment.”“Let go of what needs to go, so life can rush in to fill that space with something beautiful.”Free Workshop: Thrive Online 2025: ⁠https://www.quietmindastrology.com/thriveworkshopThrive Onilne 2025 ⁠https://www.quietmindastrology.com/thriveFree Weekly Horoscopes & Exclusive offers: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://www.quietmindastrology.com/freehoroscopes⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Free Vedic Birth Chart & Training:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://www.quietmindastrology.com/freebirthchart⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://www.instagram.com/quietmindastrology⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://www.quietmindastrology.com/youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Mentorship Waitlist:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://www.quietmindastrology.com/mentorship⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

This week's public lands update covers developments from April 3 through April 11, with a quick rewind to catch a few major stories we missed last week (because hey, I'm just a girl, and the news cycle waits for no one)Topics Covered This Week:On April 3rd, Agriculture Secretary Brooke Rollins issued a memo that designates 112 million acres of National Forest lands as part of an “emergency” Secretary of the Interior Doug Burgum quietly issued Order No. 3426, requiring all national park closures or service changes to be approved by political leadership in D.C. (even those made for urgent safety reasons.)One day after the order, National Park Service employees received another “Fork in the Road” buyout offer, asking staff to resign by midnight on April 9.During the Senate's budget reconciliation vote-a-rama on April 6, a proposed amendment to ban the sale of public lands failed, 48 to 51. On April 10, the House passed the reconciliation in a 216 - 214 vote.On April 8th, the Department of the Interior announced that the Colosseum Mine in California can resume mining operations under its existing Bureau of Land Management-approved plan. On April 8, 2025, the Interior Department also revealed a set of actions to revitalize the coal industry, emphasizing coal as a cornerstone of American energy dominance.The next day on April 9th, the Department of the Interior announced more than $13 million in grants aimed at revitalizing coal country by reclaiming abandoned mine lands in North Dakota, Tennessee, and Texas.On April 9th, over 60 outdoor industry companies have come together under a new coalition, Brands for Public Lands, to fight the increasing threats facing America's wild landscapes. Two major announcements dropped on April 10th from the Department of the Interior that together mark a sharp acceleration in fossil fuel development.Phase 2 of the Agency Reorganization and Reduction Plan is due April 14, and more federal layoffs and budget cuts could follow. Vote in the REI Board Election: https://vote.escvote.com/REI/ Have tips, testimonials, or insights on public land changes? Submit them through our Google Form (⁠⁠https://forms.gle/JwC73G8wLvU6kedc9⁠⁠)Links & Resources:https://www.usda.gov/sites/default/files/documents/sm-1078-006.pdf https://www.usda.gov/about-usda/news/press-releases/2025/04/04/secretary-rollins-announces-sweeping-reforms-protect-national-forests-and-boost-domestic-timber https://www.nrdc.org/press-releases/usdas-logging-emergency-cover-widespread-forest-destruction https://www.nrdc.org/media/executive-orders-direct-massive-expansion-logging-public-lands https://www.doi.gov/document-library/secretary-order/so-3426-ensuring-national-parks-are-open-and-accessible https://www.npca.org/articles/7868-parks-group-warns-secretary-burgum-s-order-will-endanger-park-visitors-and https://www.outdooralliance.org/blog/2025/4/8/public-land-sell-offs-back-on-the-table-in-budget-reconciliation https://www.npca.org/articles/7967-trump-administration-promotes-unauthorized-mining-in-mojave-national https://www.blm.gov/announcement/colosseum-mine-california-given-go-ahead-continue-mining-operation https://www.doi.gov/pressreleases/department-interior-moves-restore-coal-industry https://www.doi.gov/pressreleases/interior-department-disburses-over-13-million-revitalize-coal-communities https://conservationalliance.com/2025/04/businesses-unite-to-defend-public-lands/ https://www.rei.com/newsroom/article/deepening-our-commitment-to-public-lands https://www.doi.gov/pressreleases/interior-announces-major-increase-gulf-america-oil-and-gas-reserves http://doi.gov/pressreleases/interior-will-no-longer-pursue-lengthy-analysis-oil-and-gas-leasing-decisions-seven https://www.opm.gov/policy-data-oversight/latest-memos/guidance-on-agency-rif-and-reorganization-plans-requested-by-implementing-the-president-s-department-of-government-efficiency-workforce-optimization-initiative.pdf

This week, Maya and QT dive into the dark side of dating and relationships — from instant deal breakers to confronting their own red flags, exposing their exes, and ranking it all in an unhinged red flag tier list. ✨ Bonus Content: https://patreon.com/wineaboutit

In today's episode, we discuss nervous system repair in the context of traumatic injury and disease with Mike Kelly, the President and CEO of NervGen. With more than three decades of pharmaceutical experience under his belt, Mike plays instrumental roles in the creation, development, and strengthening of a number of pharma companies.  What's his primary goal? To constantly innovate medical technology for people across the globe… NervGen is a clinical-stage biotech company advancing innovative therapies for neurological recovery. Their lead drug candidate, NVG-291, is currently being evaluated in a Phase 1b/2a clinical trial for spinal cord injury. Additionally, they have launched preclinical studies for NVG-300 – a promising new development candidate, in models of ischemic stroke, amyotrophic lateral sclerosis (ALS), and spinal cord injury. Hit play to find out: Where NervGen's technology comes from. What nervous system regeneration looks like at a molecular level.  How clinical trials progress from animals to humans.  The ways that biomarker results can indicate breakthroughs in science.  Be sure to follow along with NerGen's cutting-edge work by visiting their website! Episode also available on Apple Podcast: http://apple.co/30PvU9C Boost Your Brainpower with 15% OFF!  Fuel your mind with BrainSupreme Supplements and unlock your full potential. Get 15% OFF your order now using this exclusive link: brainsupreme.co/discount/findinggenius Hurry—your brain deserves the best!